The FDA Backdoor to MDMA Rescheduling
FDA rescheduling may provide a compelling model for efforts to decriminalize and destigmatize other substances moving forward.

FDA rescheduling may provide a compelling model for efforts to decriminalize and destigmatize other substances moving forward.
The telemedicine extension is not just for psychedelics; easing these restrictions means relaxing them for other controlled substances as well.
Key takeaways from a virtual panel discussion with three leading psychedelic policy advocates.
The Biden Administration has the opportunity to be the first administration to rid our legal system of cannabis regulation chaos.
Instead of fueling the long-failed War on Drugs by repressing kratom, the FDA should strengthen consumer confidence by creating uniform regulations.
By Scott Burris There’s so much we still don’t know about the prescription opioid problem. The partial remedies advanced so far reflect this: Prescription Drug Monitoring Programs, which in essence define the problem as doctor-shopping patients; treatment guidelines, which define the problem as doctors without expertise; and crackdowns on “pill-mills,” which see the issue as…